CannaGrowth.com | Week in Review: Rescheduling marijuana in NJ, Cleveland’s limits on MMJ locations & FDA + CBD
27190
post-template-default,single,single-post,postid-27190,single-format-standard,ajax_fade,page_not_loaded,,vertical_menu_enabled,side_area_uncovered_from_content,qode-theme-ver-7.2,wpb-js-composer js-comp-ver-4.5.1,vc_responsive

Week in Review: Rescheduling marijuana in NJ, Cleveland’s limits on MMJ locations & FDA + CBD

03 Nov Week in Review: Rescheduling marijuana in NJ, Cleveland’s limits on MMJ locations & FDA + CBD

By Omar Sacirbey, John Schroyer and Kristen Nichols A New Jersey court tells the state to review how it classifies marijuana, Cleveland imposes strict limits on where MMJ companies can locate, and the FDA issues warnings to CBD producers. Here’s a closer look at some notable developments in the marijuana industry over the past week. Cannabis schedule review New Jersey – which is home to five medical cannabis dispensaries – made news when a state appeals court ruled that the Division of Consumer Affairs must review marijuana’s classification as a Schedule 1 substance. Bigger news than ... Week in Review: Rescheduling marijuana in NJ, Cleveland’s limits on MMJ locations & FDA + CBD is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

The post Week in Review: Rescheduling marijuana in NJ, Cleveland’s limits on MMJ locations & FDA + CBD appeared first on InvestinCannabis.com.

No Comments

Sorry, the comment form is closed at this time.